1.Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients.
Xiuxiu WU ; Wenshuai XU ; Jun WANG ; Xinlun TIAN ; Zhuang TIAN ; Kaifeng XU
Frontiers of Medicine 2019;13(2):259-266
Lymphangioleiomyomatosis (LAM) is a rare diffuse cystic lung disease. Knowledge on LAM-related pulmonary hypertension (PH) is limited. This study aimed to analyze the clinical characteristics of LAM with elevated pulmonary artery pressure (PAP) and evaluate the potential efficacy of sirolimus. The study involved 50 LAM patients who underwent echocardiography. According to the tricuspid regurgitation velocity (TRV), these patients were divided into the TRV ⩽ 2.8 m/s group and TRV > 2.8 m/s group. Both groups comprised 25 females with an average age of 38.6 ± 8.1 and 41.5 ± 8.9 years. In the TRV > 2.8 m/s group, the estimated systolic PAP (SPAP) was significantly elevated (52.08 ± 12.45 mmHg vs. 30.24 ± 5.25 mmHg, P < 0.01). Linear analysis showed that SPAP was correlated with forced expiratory volume in 1 s (FEV), diffusing capacity of the lungs for carbon monoxide, alveolar arterial oxygen gradient (PO), and 6 min walking distance (r =-0.392, -0.351, 0.450, and -0.591, respectively; P < 0.05), in which PO was a risk factor for SPAP elevation (β = 0.064, OR = 1.066, P < 0.05). Moreover, in 10 patients who received sirolimus therapy, SPAP decreased from 57.0 12.6 mmHg to 35.2 ± 11.1 mmHg. The study showed that LAM patients with PH exhibit poor pulmonary function and hypoxemia and may benefit from sirolimus treatment.
Adult
;
Carbon Monoxide
;
analysis
;
Echocardiography
;
Exercise Test
;
Female
;
Hemodynamics
;
Humans
;
Hypertension, Pulmonary
;
physiopathology
;
therapy
;
Logistic Models
;
Lymphangioleiomyomatosis
;
physiopathology
;
therapy
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Oxygen
;
blood
;
therapeutic use
;
Respiratory Function Tests
;
Sirolimus
;
therapeutic use
2.Interferon-α salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation.
Xiaodong MO ; Xiaohui ZHANG ; Lanping XU ; Yu WANG ; Chenhua YAN ; Huan CHEN ; Yuhong CHEN ; Wei HAN ; Fengrong WANG ; Jingzhi WANG ; Kaiyan LIU ; Xiaojun HUANG
Frontiers of Medicine 2019;13(2):238-249
The efficacy of salvage interferon-α (IFN-α) treatment was investigated in patients with unsatisfactory response to minimal residual disease (MRD)-directed donor lymphocyte infusion (DLI) (n = 24). Patients who did not become MRD-negative at 1 month after DLI were those with unsatisfactory response and were eligible to receive salvage IFN-α treatment within 3 months of DLI. Recombinant human IFN-α-2b injections were subcutaneously administered 2-3 times a week for 6 months. Nine (37.5%), 6 (25.0%), and 3 (12.5%) patients became MRD-negative at 1, 2, and > 2 months after the salvage IFN-α treatment, respectively. Two-year cumulative incidences of relapse and non-relapse mortality were 35.9% and 8.3%, respectively. Two-year probabilities of event-free survival, disease-free survival, and overall survival were 51.6%, 54.3%, and 68.0%, respectively. Outcomes of patients subjected to salvage IFN-α treatment after DLI were significantly better than those with persistent MRD without IFN-α treatment. Moreover, clinical outcomes were comparable between the salvage DLI and IFN-α treatment groups. Thus, salvage IFN-α treatment may help improve the outcome of patients with unsatisfactory responses to MRD-directed DLI and could be a potential salvage treatment for these patients after allogeneic hematopoietic stem cell transplantation.
Adolescent
;
Adult
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Beijing
;
Child
;
Child, Preschool
;
Female
;
Graft Survival
;
Graft vs Host Disease
;
mortality
;
Hematopoietic Stem Cell Transplantation
;
Humans
;
Interferon-alpha
;
therapeutic use
;
Leukemia, Myeloid, Acute
;
mortality
;
therapy
;
Lymphocyte Transfusion
;
Male
;
Middle Aged
;
Myelodysplastic Syndromes
;
mortality
;
therapy
;
Neoplasm, Residual
;
Recurrence
;
Salvage Therapy
;
Survival Analysis
;
Transplantation Conditioning
;
Transplantation, Homologous
;
Young Adult
3.Rdh13 deficiency weakens carbon tetrachloride-induced liver injury by regulating Spot14 and Cyp2e1 expression levels.
Xiaofang CUI ; Benting MA ; Yan WANG ; Yan CHEN ; Chunling SHEN ; Ying KUANG ; Jian FEI ; Lungen LU ; Zhugang WANG
Frontiers of Medicine 2019;13(1):104-111
Mitochondrion-localized retinol dehydrogenase 13 (Rdh13) is a short-chain dehydrogenase/reductase involved in vitamin A metabolism in both humans and mice. We previously generated Rdh13 knockout mice and showed that Rdh13 deficiency causes severe acute retinal light damage. In this study, considering that Rdh13 is highly expressed in mouse liver, we further evaluated the potential effect of Rdh13 on liver injury induced by carbon tetrachloride (CCl). Although Rdh13 deficiency showed no significant effect on liver histology and physiological functions under regular culture, the Rdh13 mice displayed an attenuated response to CCl-induced liver injury. Their livers also exhibited less histological changes and contained lower levels of liver-related metabolism enzymes compared with the livers of wild-type (WT) mice. Furthermore, the Rdh13 mice had Rdh13 deficiency and thus their liver cells were protected from apoptosis, and the quantity of their proliferative cells became lower than that in WTafter CCl exposure. The ablation of Rdh13 gene decreased the expression levels of thyroid hormone-inducible nuclear protein 14 (Spot14) and cytochrome P450 (Cyp2e1) in the liver, especially after CCl treatment for 48 h. These data suggested that the alleviated liver damage induced by CCl in Rdh13 mice was caused by Cyp2e1 enzymes, which promoted reductive CCl metabolism by altering the status of thyroxine metabolism. This result further implicated Rdh13 as a potential drug target in preventing chemically induced liver injury.
Alcohol Oxidoreductases
;
deficiency
;
genetics
;
Animals
;
Carbon Tetrachloride Poisoning
;
enzymology
;
Chemical and Drug Induced Liver Injury
;
enzymology
;
pathology
;
Cytochrome P-450 CYP2E1
;
metabolism
;
Female
;
Immunohistochemistry
;
Liver
;
drug effects
;
enzymology
;
pathology
;
Male
;
Mice
;
Mice, 129 Strain
;
Mice, Inbred C57BL
;
Mice, Knockout
;
Nuclear Proteins
;
metabolism
;
Transcription Factors
;
metabolism
4.Characterization of hidden rules linking symptoms and selection of acupoint using an artificial neural network model.
Won-Mo JUNG ; In-Soo PARK ; Ye-Seul LEE ; Chang-Eop KIM ; Hyangsook LEE ; Dae-Hyun HAHM ; Hi-Joon PARK ; Bo-Hyoung JANG ; Younbyoung CHAE
Frontiers of Medicine 2019;13(1):112-120
Comprehension of the medical diagnoses of doctors and treatment of diseases is important to understand the underlying principle in selecting appropriate acupoints. The pattern recognition process that pertains to symptoms and diseases and informs acupuncture treatment in a clinical setting was explored. A total of 232 clinical records were collected using a Charting Language program. The relationship between symptom information and selected acupoints was trained using an artificial neural network (ANN). A total of 11 hidden nodes with the highest average precision score were selected through a tenfold cross-validation. Our ANN model could predict the selected acupoints based on symptom and disease information with an average precision score of 0.865 (precision, 0.911; recall, 0.811). This model is a useful tool for diagnostic classification or pattern recognition and for the prediction and modeling of acupuncture treatment based on clinical data obtained in a real-world setting. The relationship between symptoms and selected acupoints could be systematically characterized through knowledge discovery processes, such as pattern identification.
Acupuncture Points
;
Acupuncture Therapy
;
Humans
;
Neural Networks (Computer)
;
Republic of Korea
;
Syndrome
5.Genome editing for the treatment of tumorigenic viral infections and virus-related carcinomas.
Lan YU ; Xun TIAN ; Chun GAO ; Ping WU ; Liming WANG ; Bei FENG ; Xiaomin LI ; Hui WANG ; Ding MA ; Zheng HU
Frontiers of Medicine 2018;12(5):497-508
Viral infections cause at least 10%-15% of all human carcinomas. Over the last century, the elucidation of viral oncogenic roles in many cancer types has provided fundamental knowledge on carcinogenetic mechanisms and established a basis for the early intervention of virus-related cancers. Meanwhile, rapidly evolving genome-editing techniques targeting viral DNA/RNA have emerged as novel therapeutic strategies for treating virus-related carcinogenesis and have begun showing promising results. This review discusses the recent advances of genome-editing tools for treating tumorigenic viruses and their corresponding cancers, the challenges that must be overcome before clinically applying such genome-editing technologies, and more importantly, the potential solutions to these challenges.
Antiviral Agents
;
therapeutic use
;
CRISPR-Cas Systems
;
Carcinoma
;
genetics
;
therapy
;
virology
;
Gene Editing
;
Genetic Predisposition to Disease
;
Genetic Therapy
;
methods
;
Humans
;
Tumor Virus Infections
;
complications
6.NKT cells in liver diseases.
Shasha ZHU ; Huimin ZHANG ; Li BAI
Frontiers of Medicine 2018;12(3):249-261
Natural killer T cells are innate-like and tissue-resident lymphocytes, which recognize lipid antigens and are enriched in the liver. Natural killer T cells play important roles in infections, tumors, autoimmune diseases, and metabolic diseases. In this study, we summarize recent findings on biology of natural killer T cells and their roles in hepatitis B virus and hepatitis C virus infection, autoimmune liver diseases, alcoholic liver disease, nonalcoholic fatty liver disease, and hepatocellular carcinoma. Controversial results from previous studies are discussed, and indicate the dynamic alteration in the role of natural killer T cells during the progression of liver diseases, which might be caused by changes in natural killer T subsets, factors skewing cytokine responses, and intercellular crosstalk between natural killer T cells and CD1d-expressing cells or bystander cells.
Animals
;
Autoimmune Diseases
;
immunology
;
Humans
;
Liver
;
pathology
;
Liver Diseases
;
immunology
;
Natural Killer T-Cells
;
immunology
7.Middle East respiratory syndrome coronavirus in pediatrics: a report of seven cases from Saudi Arabia.
Sarah H ALFARAJ ; Jaffar A AL-TAWFIQ ; Talal A ALTUWAIJRI ; Ziad A MEMISH
Frontiers of Medicine 2019;13(1):126-130
Infection with Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012 as an important respiratory disease with high fatality rates of 40%-60%. Despite the increased number of cases over subsequent years, the number of pediatric cases remained low. A review of studies conducted from June 2012 to April 19, 2016 reported 31 pediatric MERS-CoV cases. In this paper, we present the clinical and laboratory features of seven patients with pediatric MERS. Five patients had no underlying medical illnesses, and three patients were asymptomatic. Of the seven cases, four (57%) patients sought medical advice within 1-7 days from the onset of symptoms. The three other patients (43%) were asymptomatic and were in contact with patients with confirmed diagnosis of MERS-CoV. The most common presenting symptoms were fever (57%), cough (14%), shortness of breath (14%), vomiting (28%), and diarrhea (28%). Two (28.6%) patients had platelet counts of < 150 × 10/L, and one patient had an underlying end-stage renal disease. The remaining patients presented with normal blood count, liver function, and urea and creatinine levels. The documented MERS-CoV Ct values were 32-38 for four of the seven cases. Two patients (28.6%) had abnormal chest radiographic findings of bilateral infiltration. One patient (14.3%) required ventilator support, and two patients (28.6%) required oxygen supplementation. All the seven patients were discharged without complications.
Adolescent
;
Child
;
Coronavirus Infections
;
diagnosis
;
physiopathology
;
Diarrhea
;
etiology
;
Dyspnea
;
etiology
;
Female
;
Fever
;
etiology
;
Humans
;
Infant
;
Lung
;
diagnostic imaging
;
Male
;
Middle East Respiratory Syndrome Coronavirus
;
genetics
;
Pleural Effusion
;
diagnostic imaging
;
Radiography, Thoracic
;
Saudi Arabia
8.Sensitivity of supplementation of thyroid hormone on treatment of idiopathic short-stature children during therapy with recombinant human growth hormone.
Wei WANG ; Shuqin JIANG ; Zhirui CUI ; Xiangyang LUO ; Lingli SHI ; Heli ZHENG
Frontiers of Medicine 2018;12(5):580-585
This study aimed to evaluate the effects of thyroid hormone supplementation on growth rate of children with idiopathic short stature (ISS) and low-normal serum free thyroxine FT4 who were receiving growth hormone therapy. We selected 64 prepubertal children with FT4 levels in the lowest third of the normal range as the lower FT4 group, and these children were divided randomly into two subgroups: L-thyroxine (L-T4)-treated subgroup was treated with L-T4 (0.5-3.0 g/(kg·d)) from the beginning of the study, and the non-L-T4-treated subgroup received placebo. We also selected 39 ISS children with FT4 in the upper two-thirds of the normal range as the higher FT4 group. During the first year, the lower FT4 group featured lower FT3, FT4, thyroid stimulating hormone (TSH), and insulin-like growth factor-I standard deviation score (IGF-I SDS) and significantly lower height velocity (HV) compared with the higher FT4 group. However, in the lower FT4 group, the L-T4-treated subgroup presented higher FT4, FT3, TSH, and IGF-I SDS concentrations and significantly higher HV compared with children in the non-L-T4-treated subgroup. In children with ISS, the negative effect of thyroid hormone deficiency on growth rate should be considered when FT4 level lies in the low-normal range prior to recombinant human growth hormone treatment.
Child
;
Female
;
Growth Disorders
;
blood
;
drug therapy
;
Human Growth Hormone
;
therapeutic use
;
Humans
;
Insulin-Like Growth Factor I
;
metabolism
;
Male
;
Recombinant Proteins
;
therapeutic use
;
Thyrotropin
;
blood
;
Thyroxine
;
blood
9.DNA methylation-based subclassification of psoriasis in the Chinese Han population.
Fusheng ZHOU ; Changbing SHEN ; Yi-Hsiang HSU ; Jing GAO ; Jinfa DOU ; Randy KO ; Xiaodong ZHENG ; Liangdan SUN ; Yong CUI ; Xuejun ZHANG
Frontiers of Medicine 2018;12(6):717-725
Psoriasis (Ps) is an inflammatory skin disease caused by genetic and environmental factors. Previous studies on DNA methylation (DNAm) found genetic markers that are closely associated with Ps, and evidence has shown that DNAm mediates genetic risk in Ps. In this study, Consensus Clustering was used to analyze DNAm data, and 114 Ps patients were divided into three subclassifications. Investigation of the clinical characteristics and copy number variations (CNVs) of DEFB4, IL22, and LCE3C in the three subclassifications revealed no significant differences in gender ratio and in Ps area and severity index (PASI) score. The proportion of late-onset ( ≥ 40 years) Ps patients was significantly higher in type I than in types II and III (P = 0.035). Type III contained the smallest proportion of smokers and the largest proportion of non-smoking Ps patients (P = 0.086). The CNVs of DEFB4 and LCE3C showed no significant differences but the CNV of IL22 significantly differed among the three subclassifications (P = 0.044). This study is the first to profile Ps subclassifications based on DNAm data in the Chinese Han population. These results are useful in the treatment and management of Ps from the molecular and genetic perspectives.
Adolescent
;
Adult
;
Aged
;
Asian Continental Ancestry Group
;
genetics
;
Case-Control Studies
;
Child
;
China
;
Cornified Envelope Proline-Rich Proteins
;
genetics
;
DNA Copy Number Variations
;
DNA Methylation
;
Female
;
Genetic Predisposition to Disease
;
Humans
;
Interleukins
;
genetics
;
Male
;
Middle Aged
;
Psoriasis
;
classification
;
genetics
;
Risk Factors
;
Young Adult
;
beta-Defensins
;
genetics
10.Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy.
Yinlong ZHANG ; Guangna LIU ; Jingyan WEI ; Guangjun NIE
Frontiers of Medicine 2018;12(6):667-677
Platelets have long been known to play critical roles in hemostasis by clumping and clotting blood vessel injuries. Recent experimental evidence strongly indicates that platelets can also interact with tumor cells by direct binding or secreting cytokines. For example, platelets have been shown to protect circulating cancer cells in blood circulation and to promote tumor metastasis. In-depth understanding of the role of platelets in cancer progression and metastasis provides promising approaches for platelet biomimetic drug delivery systems and functional platelet-targeting strategies for effective cancer treatment. This review highlights recent progresses in platelet membrane-based drug delivery and unique strategies that target tumor-associated platelets for cancer therapy. The paper also discusses future development opportunities and challenges encountered for clinical translation.
Animals
;
Antineoplastic Agents
;
chemistry
;
pharmacology
;
Biomimetic Materials
;
chemistry
;
Blood Platelets
;
cytology
;
Drug Carriers
;
chemistry
;
Humans
;
Models, Animal
;
Nanomedicine
;
methods
;
Nanostructures
;
chemistry
;
Neoplasms
;
drug therapy